Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER_GOV × Uveal Melanoma × Clear all

Phase

Status

Completed 3 Not yet recruiting 2 Unknown 1 Recruiting 1

Sponsor Class

OTHER 20 INDUSTRY 15 OTHER_GOV 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 41 Neoplasms 28 Uterine Cervical Neoplasms 21 Prostatic Neoplasms 19 Carcinoma, Non-Small-Cell Lung 19 Stomach Neoplasms 17 Colorectal Neoplasms 17 Carcinoma, Hepatocellular 16 Multiple Myeloma 10 Recurrence 9 Ovarian Neoplasms 9 Esophageal Squamous Cell Carcinoma 9 Pancreatic Neoplasms 8 Lymphoma 8 Esophageal Neoplasms 8 Lung Neoplasms 7 Leukemia, Myeloid, Acute 7 Endometrial Neoplasms 7 Leukemia 6 Gastrointestinal Neoplasms 6 Triple Negative Breast Neoplasms 5 Rectal Neoplasms 5 Papillomavirus Infections 5 Hematologic Neoplasms 5 Disease 5 Colonic Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Brain Neoplasms 5 Urinary Bladder Neoplasms 4 Small Cell Lung Carcinoma 4

Interventions

Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06519266 2024-11-25

SCANDIUM-III

Vastra Gotaland Region

Phase 3 Recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡